戻る
Edwards Lifesciences Corp (EW)価格
EW 株価推移チャート
EW 財務
Edwards Lifesciences Corp
$83.46
-1.05%
$-0.89
終値： Jan 20, 16:00:00 GMT-5
$84
0.64%
$0.54
アフターマーケット：Jan 20, 20:00:00 GMT-5
B
最終スコア
主要データ
前終値
$84.35
始値
$83.72
当日レンジ
$82.82 - $85.16
52週レンジ
$65.94 - $87.89
取引高
3.2M
平均取引高
3.9M
1株当たり利益(TTM)
2.33
配当利回り
--
時価総額
$48.7B
EWとは何ですか？
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,800 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.